Nuvation Bio Inc. Files 8-K on Shareholder Votes and Events

Ticker: NUVB · Form: 8-K · Filed: Sep 5, 2024 · CIK: 1811063

Sentiment: neutral

Topics: corporate-action, filing-update

Related Tickers: NUVB

TL;DR

Nuvation Bio filed an 8-K on Sep 3rd covering shareholder votes and other events. Check for details on stock and warrants.

AI Summary

Nuvation Bio Inc. filed an 8-K on September 5, 2024, reporting on matters submitted to a vote of security holders and other events that occurred on September 3, 2024. The filing details the company's corporate structure, including its common stock and warrants, and provides its principal executive office address in New York.

Why It Matters

This filing provides an update on corporate actions and events at Nuvation Bio Inc., which could impact investors' understanding of the company's governance and operational status.

Risk Assessment

Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain significant new risks or material adverse information.

Key Players & Entities

FAQ

What specific matters were submitted to a vote of Nuvation Bio Inc.'s security holders on or before September 3, 2024?

The filing indicates that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in the excerpt.

What 'Other Events' are being reported by Nuvation Bio Inc. as of September 3, 2024?

The filing states that 'Other Events' occurred on September 3, 2024, but the nature of these events is not detailed in the provided text.

What is the principal executive office address for Nuvation Bio Inc.?

The principal executive offices of Nuvation Bio Inc. are located at 1500 Broadway, Suite 1401, New York, NY 10036.

What is the telephone number for Nuvation Bio Inc.?

The registrant's telephone number, including area code, is (332) 208-6102.

What is the Commission File Number for Nuvation Bio Inc.?

The Commission File Number for Nuvation Bio Inc. is 001-39351.

Filing Stats: 1,183 words · 5 min read · ~4 pages · Grade level 9.7 · Accepted 2024-09-05 16:35:57

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: September 5, 2024 NUVATION BIO INC. By: /s/ David Hung, M.D. Name: David Hung, M.D. Title: Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing